OncoCyte Corp (44) | Uncategorized (12)
Recent Contracts
-
Description of Securities
(Filed With SEC on March 11, 2022)
-
Addendum No. 2 to Exclusive Sublicense Agreement in the PRC Territory, dated December 5, 2021, by and among Razor Genomics, Inc., Oncocyte Corporation, Encore Clinical, Inc., and...
(Filed With SEC on December 8, 2021)
-
Description of Securities
(Filed With SEC on March 19, 2021)
-
Exclusive Sublicense Agreement in the PRC Territory
(Filed With SEC on December 16, 2020)
-
Reduction in Salary Agreement between OncoCyte Corporation and Lyndal Hesterberg
(Filed With SEC on September 28, 2020)
-
Reduction in Salary Agreement between OncoCyte Corporation and Albert Parker
(Filed With SEC on September 28, 2020)
-
Reduction in Salary Agreement between OncoCyte Corporation and Tony Kalajian
(Filed With SEC on September 28, 2020)
-
Acknowledgement and Agreement, dated May 7, 2020, between OncoCyte Corporation and Ronald Andrews
(Filed With SEC on May 12, 2020)
-
Acknowledgement and Agreement, dated May 7, 2020, between OncoCyte Corporation and Mitchell Levine
(Filed With SEC on May 12, 2020)
-
Acknowledgement and Agreement, dated May 7, 2020, between OncoCyte Corporation and Lyndal Hesterberg
(Filed With SEC on May 12, 2020)
-
Description of Securities
(Filed With SEC on March 26, 2020)
-
(Filed With SEC on March 26, 2020)
